Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fibronectin Rat Protein | Login | Fibronectin Rat Protein | ||||||||||||||||
|
||||||||||||||||||
HIF1A Human, His Protein | Login | HIF1A Human, His Protein | ||||||||||||||||
|
||||||||||||||||||
HIF1A Human (85 a.a.) Protein | Login | HIF1A Human (85 a.a.) Protein | ||||||||||||||||
|
||||||||||||||||||
HNRNPC Human Protein | Login | HNRNPC Human Protein | ||||||||||||||||
|
||||||||||||||||||
KRAS Human Protein | Login | KRAS Human Protein | ||||||||||||||||
|
||||||||||||||||||
NAPA Human Protein | Login | NAPA Human Protein | ||||||||||||||||
|
||||||||||||||||||
Anti-Human Adiponectin | Login | Anti-Human Adiponectin | ||||||||||||||||
|
||||||||||||||||||
Anti-Human FGF-basic | Login | Anti-Human FGF-basic | ||||||||||||||||
|
||||||||||||||||||
Anti-Human FGF-5 | Login | Anti-Human FGF-5 | ||||||||||||||||
|
||||||||||||||||||
Anti-Human VEGF | Login | Anti-Human VEGF | ||||||||||||||||
|
||||||||||||||||||
Affinity Purified Anti-MOUSE IgA (alpha chain) (RABBIT) | Login | Affinity Purified Anti-MOUSE IgA (alpha chain) (RABBIT) | ||||||||||||||||
|
||||||||||||||||||
Rabbit anti Mouse IgG (H&,L) | Login | Rabbit anti Mouse IgG (H&,L) | ||||||||||||||||
|
||||||||||||||||||
Testosterone | Login | Testosterone | ||||||||||||||||
|
||||||||||||||||||
Pancreatic Polypeptide Rat | Login | Pancreatic Polypeptide Rat | ||||||||||||||||
|
||||||||||||||||||
Rat CD8 alpha Antibody (FITC) | Login | Rat CD8 alpha Antibody (FITC) | ||||||||||||||||
|
||||||||||||||||||
Mouse CD16/CD32 Antibody | Login | Mouse CD16/CD32 Antibody | ||||||||||||||||
|
||||||||||||||||||
Affinity Purified Anti-MOUSE IgG IgA IgM (H&L) (GOAT) (Min X Bv, Hs, Hu Serum Proteins) | Login | Affinity Purified Anti-MOUSE IgG IgA IgM (H&L) (GOAT) (Min X Bv, Hs, Hu Serum Proteins) | ||||||||||||||||
|
||||||||||||||||||
Mouse CD123 Antibody | Login | Mouse CD123 Antibody | ||||||||||||||||
|
||||||||||||||||||
UBIQUITIN | Login | UBIQUITIN | ||||||||||||||||
|
||||||||||||||||||
Goat F(ab\',)2 Anti-Rabbit IgG (H+L chain specific) Absorbed against human &, mouse immunoglobulins | Login | Goat F(ab\',)2 Anti-Rabbit IgG (H+L chain specific) Absorbed against human &, mouse immunoglobulins | ||||||||||||||||
|
||||||||||||||||||
p38a/SAPK2 Human | Login | p38a/SAPK2 Human | ||||||||||||||||
|
||||||||||||||||||
VEGF (121) Human Sf9 | Login | VEGF (121) Human Sf9 | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human Galectin-3 | Login | Recombinant Human Galectin-3 | ||||||||||||||||
|
||||||||||||||||||
Hyaluronidase Testicular (Bovine) | Login | Hyaluronidase Testicular (Bovine) | ||||||||||||||||
|
||||||||||||||||||
PRL-R Rainbow Trout | Login | PRL-R Rainbow Trout | ||||||||||||||||
|